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Abstract
We report the clonal dissemination of ST201 Enterococcus
faecalis carrying Tn5382–vanB2 and of CC17–ST64 Enterococcus
faecium carrying Tn5382–vanB2–ISEnfa110 among 16 hospitals in
four geographically distant regions in Chile. This is the ﬁrst
epidemiological characterization of vancomycin resistance in
Chile, and also the ﬁrst report of interhospital dissemination of
enterococcal vanB2 in South America.
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Vancomycin-resistant enterococci (VRE) have emerged among
the major nosocomial pathogens in many parts of the world.
Although several glycopeptide resistance mechanisms have
been described in enterococci, the acquired genotypes vanA
and vanB are the most common. VanB-type resistance is
encoded by the vanB gene cluster, of which three subtypes
exist—vanB1, vanB2, and vanB3—that are distinguished on the
basis of sequence variations in the ligase-encoding gene vanB.
The vanB2 subtype has been found in human and animal entero-
coccal isolates, carrying transposons Tn5382 and Tn1549,
from the USA and different countries in Europe [1–7].
A total of 70 VRE isolates (ten Enterococcus faecalis and 60
Enterococcus faecium) were submitted to the National Refer-
ence Institute in Santiago, Chile (http://www.ispch.cl), from 16
hospitals in four geographically distant regions of Chile: Santi-
ago (12 hospitals, 59 isolates), Concepcio´n (two hospitals, six
isolates), Talcahuano (one hospital, four isolates), and Temuco
(one hospital, one isolate). VRE isolates were recovered from
non-simultaneously hospitalized patients between 2003 and
2005; the samples included 34 faecal swabs, 15 urine sampless,
six wound exudates, three blood cultures, two peritoneal
liquids, two gastric liquids, and eight samples of undetermined
origin. Susceptibility to different antibiotics was tested using
the agar dilution method following the CLSI recommendations.
Pulsed-ﬁeld gel electrophoresis (PFGE) of SmaI-digested DNA
was performed to analyse the genetic relatedness of the VRE
isolates, using the CHEF DR-III apparatus (BioRad, Birming-
ham, UK). The electrophoresis conditions were as follows:
6 V/cm2; 22 h; initial switch time 5 s; and ﬁnal switch time
35 s. One isolate per clone was further typed by multilocus
sequence typing (MLST) (http://www.mlst.net). The presence
of the vanB2 gene, as well as the arrangement of the vanB
cluster and the surrounding regions (vanSB–vanYB, Tn5382,
vanXB–ORFC, pbp5–Tn5382, ISEnfa110, and ISEnfa200), was
determined by PCR and sequencing [2]. Carriage of virulence
factors (esp, hyl, cylLS–M–A–B gelE–fsrA–C) and antibiotic
resistance genes (ermB, tetM, tetL, ant6, aph3¢-IIIa, and
aac(6¢)–aph(2¢¢)) was investigated in the different clones by
PCR with speciﬁc primers [2]. Transferability of vancomycin
resistance determinants was tested by conjugation using
the ﬁlter method with both E. faecalis JH2-2 and E. faecium
GE-1 as recipients (rifampin/fusidic acid-resistant, vancomycin-
susceptible) using a donor/recipient ratio of 1 : 10 [8]. All
donor strains were susceptible to rifampicin and fusidic acid,
and transconjugants were selected on BHI agar plates supple-
mented with rifampin (100 mg/L), fusidic acid (20 mg/L), and
vancomycin (16 mg/L).
All 70 VRE isolates harboured the vanB2 gene (GeneBank
accession number: AF173641) and were resolved into seven
PFGE types (two for E. faecalis and for ﬁve E. faecium), using
the previously described PFGE typing criteria [9]. Co-resis-
tance to erythromycin, tetracycline, ciproﬂoxacin, and peni-
cillins (only in E. faecium clones), and high-level resistance to
aminoglycosides, was observed in all PFGE types, although
three isolates of PFGE pattern A remained susceptible to
high levels of gentamicin (Table 1). Antibiotic resistance
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genes detected by PCR corroborated the resistance pheno-
type, except in one tetracycline-resistant E. faecium isolate,
for which the mechanism responsible for tetracycline resis-
tance was not detected. The nucleotide sequence of the
pbp5 gene of one ampicillin-resistant E. faecium isolate of
clone B revealed seven amino acid changes (H470Q, M485A,
N496K, A499T, E525D, E629V, and P667S), and also a
Ser466¢ insertion. Both types of modiﬁcation have been pre-
viously associated with overproduction of penicillin-binding
protein 5 [10–12]. No vanB2 transconjugants were obtained
using either the E. faecalis or the E. faecium recipients at a
limiting transfer frequency of 10)9.
All ﬁve E. faecium PFGE clones were of the same MLST type
and corresponded to the hospital-adapted clonal complex
CC17–ST64 (7-1-1-1-1-1-1) [13,14]. The E. faecalis PFGE
clones were also identical according to MLST, and were
included in a new singleton, ST201 (1-7-1-7-25-1-4), that has
been registered at the MLST website (http://efaecalis.mlst.net/).
Nucleotide analysis of the glycopeptide resistance element in
all different clones conﬁrmed the association of the vanB2
cluster with Tn5382. All E. faecium clones contained ISEn-
fa110 between the IRL and the vanRB gene, whereas the
E. faecalis clones did not carry ISEnfa110 or ISEnfa200.
Amplicons of vanXB–ORFC were obtained from the seven
clones, and corresponded to the AF203412 allele previously
deposited in GeneBank. Virulence factor genes were
detected in E. faecalis clones, and the esp gene was found in
four of the ﬁve E. faecium clones (Table 1).
The vanB2 cluster can be transferred because of its associa-
tion with the Tn5382 element containing ISEnfa110, and trans-
fer of this element frequently mobilizes a large chromosomal
element containing a mutated pbp5 gene, which confers ampi-
cillin resistance to E. faecium isolates. In contrast, isolates of
the ﬁve ampicillin-resistant E. faecium CC17 PFGE types and of
the two E. faecalis PFGE types described here were unable to
transfer the vancomycin resistance determinant.
The ST64 E. faecium Tn5382–vanB2–ISEnfa110-containing
clones and the ST201 E. faecalis Tn5382–vanB2-containing
clones have been found in 16 hospitals in four regions in
Chile. This is the ﬁrst epidemiological characterization of the
VanB phenotype in clinical isolates from South America,
showing that E. faecium CC17 is distributed worldwide.
Moreover, a new singleton named ST201 E. faecalis has been
found. The apparent absence of vanB2 transfer by conjuga-
tion in the strains studied here indicates that clonal dissemi-
nation of the VanB enterococcal strains was critical in the
spread of vancomycin resistance among the 16 hospitals.
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Talcahuano (1)
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E (1) Concepcion (1) HLR-Ags, Van, Lev, Tet, Ery, SxT vanB2, Tn5382 aac(6¢)–aph(2¢¢), aph3, tetM, erm(B),
esp, hyl, gelE–fsrA–C, cylLS–M–A–B
Pen, penicillin resistance; Amp, ampicillin resistance; HLR-Ags, high-level resistance to aminoglycosides; Van, vancomycin resistance; Lev, levoﬂoxacin resistance;
Tet, tetracycline resistance; Ery, erythromycin resistance; SUT, sulphamethoxazole resistance; PFGE, pulsed-ﬁeld gel electrophoresis.
aThree isolates remained susceptible to high levels of gentamicin, and the aac(6¢)–aph(2¢¢) gene was not detected.
CMI Research Notes 587
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 586–598
2. Dahl KH, Lundblad EW, Rokenes TP, Olsvik O, Sundsfjord A.
Genetic linkage of the vanB2 gene cluster to Tn5382 in vancomycin-
resistant enterococci and characterization of two novel insertion
sequences. Microbiology 2000; 146: 1469–1479.
3. Garnier F, Taourit S, Glaser P, Courvalin P, Galimand M. Character-
ization of transposon Tn1549 conferring VanB-type resistance in
Enterococcus spp. Microbiology 2000; 146: 1481–1489.
4. Granlund M, Carlsson C, Edebro H, Emanuelsson K, Lundholm R.
Nosocomial outbreak of vanB2 vancomycin-resistant Enterococcus
faecium in Sweden. J Hosp Infect 2006; 62: 254–256.
5. Lu JJ, Chang TY, Perng CL, Lee SY. The vanB2 gene cluster of the
majority of vancomycin-resistant Enterococcus faecium isolates from
Taiwan is associated with the pbp5 gene and is carried by Tn5382
containing a novel insertion sequence. Antimicrob Agents Chemother
2005; 49: 3937–3939.
6. Nebreda T, Oteo J, Aldea C et al. Hospital dissemination of a clonal
complex 17 vanB2-containing Enterococcus faecium. J Antimicrob Chemo-
ther 2007; 59: 806–807.
7. Torres C, Tenorio C, Portillo A et al. Intestinal colonization by vanA
or vanB2-containing enterococcal isolates of healthy animals in Spain.
Microb Drug Resist 2003; 8: S47–S52.
8. Dunny GM, Craig RA, Carron RL, Clewell DB. Plasmid transfer in
Streptococcus faecalis: production of multiple sex pheromones by
recipients. Plasmid 1979; 2: 454–465.
9. Morrison D, Woodford N, Barrett SP, Sisson P, Cookson BD. DNA
banding pattern polymorphism in vancomycin-resistant Enterococcus
faecium and criteria for deﬁning strains. J Clin Microbiol 1999; 37:
1084–1091.
10. Poeta P, Costa D, Igrejas G et al. Polymorphisms of the pbp5 gene
and correlation with ampicillin resistance in Enterococcus faecium iso-
lates of animal origin. J Med Microbiol 2007; 56: 236–240.
11. Rice LB, Carias LL, Hutton-Thomas R, Sifaoui F, Gutmann L, Rudin SD.
Penicillin-binding protein 5 and expression of ampicillin resistance in
Enterococcus faecium. Antimicrob Agents Chemother 2001; 45: 1480–1486.
12. Rybkine T, Mainardi JL, Sougakoff W, Collatz E, Gutmann L. Penicil-
lin-binding protein 5 sequence alterations in clinical isolates of Entero-
coccus faecium with different levels of beta-lactam resistance. J Infect
Dis 1998; 178: 159–163.
13. Top J, Willems R, Blok H et al. Ecological replacement of Enterococcus
faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin
Microbiol Infect 2006; 13: 316–319.
14. Willems RJ, Top J, San Santen M et al. Global spread of vancomycin-
resistant Enterococcus faecium from distinct nosocomial genetic com-
plex. Emerg Infect Dis 2005; 11: 821–828.
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Abstract
Thirty consecutive Acinetobacter baumannii isolates producing
carbapenem-hydrolysing oxacillinases, OXA-23 or OXA-58,
were recovered from patients hospitalized in Rome, Italy,
between January and November 2007. Among these isolates,
two clones not associated with the European clones I or II were
observed. The oxacillinase-encoding genes were plasmid- or
chromosome-borne. This study reports the dissemination of
carbapenem-resistant A. baumannii belonging to two clones
among several units in a single hospital and emphasizes the
ability of A. baumannii to cause epidemic/endemic outbreaks and
also to acquire various resistance genes circulating in the
hospital environment.
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Acinetobacter baumannii is an opportunistic pathogen present
in healthcare environments, due to its ability to survive in
human skin and dry surfaces to a greater extent than other
hospital-acquired Gram-negative bacilli [1]. This microorgan-
ism produces chromosomally encoded class C and OXA-51/
69-like b-lactamases, with their expression varying according
to the presence of ISAba [2–4]. This genetic background
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